CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aileron Therapeutics, Inc., a biopharmaceutical company developing and advancing a revolutionary class of drugs called Stapled Peptides, today announced the company’s participation in several upcoming scientific conferences and biotechnology industry events.
